Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$42.56 - $59.82 $14,896 - $20,937
350 New
350 $19,000
Q4 2022

Jan 24, 2023

SELL
$41.39 - $81.0 $37,582 - $73,548
-908 Reduced 4.42%
19,654 $885,000
Q3 2022

Nov 04, 2022

SELL
$72.36 - $113.1 $286,545 - $447,876
-3,960 Reduced 16.15%
20,562 $1.49 Million
Q2 2022

Jul 22, 2022

BUY
$87.2 - $114.05 $377,924 - $494,292
4,334 Added 21.47%
24,522 $2.63 Million
Q1 2022

May 09, 2022

BUY
$94.19 - $124.49 $356,791 - $471,568
3,788 Added 23.1%
20,188 $2.24 Million
Q4 2021

Feb 15, 2022

BUY
$119.57 - $139.07 $929,776 - $1.08 Million
7,776 Added 90.17%
16,400 $2.1 Million
Q3 2021

Nov 12, 2021

BUY
$109.17 - $142.35 $701,198 - $914,314
6,423 Added 291.82%
8,624 $1.15 Million
Q2 2021

Jul 23, 2021

BUY
$100.34 - $115.69 $100 - $115
1 Added 0.05%
2,201 $238,000
Q1 2021

May 10, 2021

SELL
$101.51 - $125.27 $448,775 - $553,818
-4,421 Reduced 66.77%
2,200 $232,000
Q4 2020

Feb 24, 2021

SELL
$85.88 - $105.36 $31,861 - $39,088
-371 Reduced 5.31%
6,621 $689,000
Q4 2020

Feb 12, 2021

SELL
$85.88 - $105.36 $315,179 - $386,671
-3,670 Reduced 34.42%
6,992 $689,000
Q3 2020

Nov 10, 2020

BUY
$72.74 - $92.5 $775,553 - $986,235
10,662 New
10,662 $855,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Bank Julius Baer & Co. Ltd, Zurich Portfolio

Follow Bank Julius Baer & Co. Ltd, Zurich and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.